Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Insulin-like growth factor-binding protein 1 and 7 concentrations are lower in obese pregnant women, women with gestational diabetes and their fetuses

Abstract

Objective:

To determine the effect of pre-existing maternal obesity and gestational diabetes mellitus (GDM) on the circulating levels of insulin growth factor-binding protein (IGFBPs) in cord and maternal plasma.

Study Design:

IGFBP-1–7 levels were measured on maternal and cord plasma from women with normal glucose tolerance (NGT) (30 non-obese and 36 obese) and GDM (44 non-obese and 26 obese) at the time of term elective cesarean section.

Result:

Maternal plasma IGFBP-1, IGFBP-6 and IGFBP-rP1 concentrations were significantly lower in NGT obese compared with NGT non-obese women and in non-obese GDM women compared with non-obese NGT women. In cord plasma, IGFBP-1–3 and IGFBP-rP1 concentrations were significantly lower in NGT obese compared with NGT non-obese women and in non-obese GDM women compared with non-obese NGT women. Significant positive correlations were observed between maternal and cord plasma IGFBP-1 and IGFBP-rP1 levels and maternal insulin resistance. In cord plasma, significant positive correlations were observed between IGFBP-1–3 and IGFBP-rP1 levels and fetal insulin resistance. Fetal birthweight was inversely correlated with maternal plasma IGFBP-1 levels and cord plasma IGFBP-1 and IGFBP-2 levels. When corrected for maternal body mass index, the only significant relationship that still existed was between cord plasma IGFBP-1 concentrations and fetal birthweight.

Conclusion:

At the time of term cesarean section, pre-existing maternal obesity and GDM are associated with lower IGFBP levels in maternal and cord plasma. Alterations in circulating IGF and IGFBPs may alter birthweight and/or neonatal adiposity. This may lead to alterations in optimal growth trajectory and lead to metabolic disorders later in life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477–2486.

    Article  CAS  Google Scholar 

  2. Callaway LK, Prins JB, Chang AM, McIntyre HD . The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Austr 2006; 184: 56–59.

    Google Scholar 

  3. Heslehurst N, Simpson H, Ells LJ, Rankin J, Wilkinson J, Lang R et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obesity Rev 2008; 9: 635–683.

    Article  CAS  Google Scholar 

  4. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J . Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003; 133: 1674S–1683S.

    Article  CAS  Google Scholar 

  5. Catalano PM, Presley L, Minium J, Mouzon SHD . Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009; 32: 1076–1080.

    Article  CAS  Google Scholar 

  6. Boney CM, Verma A, Tucker R, Vohr BR . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290–e296.

    Article  Google Scholar 

  7. Chu SY, Bachman DJ, Callaghan WM, Whitlock EP, Dietz PM, Berg CJ et al. Association between obesity during pregnancy and increased use of health care. N Engl J Med 2008; 358: 1444–1453.

    Article  CAS  Google Scholar 

  8. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002; 417: 945–948.

    Article  CAS  Google Scholar 

  9. Fowden AL . The insulin-like growth factors and feto-placental growth. Placenta 2003; 24: 803–812.

    Article  CAS  Google Scholar 

  10. Baker J, Liu JP, Robertson EJ, Efstratiadis A . Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73–82.

    Article  CAS  Google Scholar 

  11. Luo ZC, Nuyt AM, Delvin E, Audibert F, Girard I, Shatenstein B et al. Maternal and fetal IGF-I and IGF-II levels, fetal growth, and gestational diabetes. J Clin Endocrinol Metab 2012; 97: 1720–1728.

    Article  CAS  Google Scholar 

  12. Firth SM, Baxter RC . Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 824–854.

    Article  CAS  Google Scholar 

  13. McIntyre HD, Chang AM, Callaway LK, Cowley DM, Dyer AR, Radaelli T et al. Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care 2010; 33: 356–360.

    Article  CAS  Google Scholar 

  14. Jansson N, Nilsfelt A, Gellerstedt M, Wennergren M, Rossander-Hulthen L, Powell TL et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr 2008; 87: 1743–1749.

    Article  CAS  Google Scholar 

  15. Olausson H, Lof M, Brismar K, Forsum E, Sohlstrom A . Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight. Br J Nutr 2010; 104: 842–848.

    Article  CAS  Google Scholar 

  16. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LFJ et al. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol 2007; 66: 322–328.

    Article  CAS  Google Scholar 

  17. Qiu C, Vadachkoria S, Meryman L, Frederick IO, Williams MA . Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus. Am J Obstetr Gynecol 2005; 193: 1691–1697.

    Article  CAS  Google Scholar 

  18. Langford K, Blum W, Nicolaides K, Jones J, McGregor A, Miell J . The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur J Clin Invest 1994; 24: 851–856.

    Article  CAS  Google Scholar 

  19. Giudice LC, Dezegher F, Gargosky SE, Dsupin BA, Delasfuentes L, Crystal RA et al. Insulin-like growth-factors and their binding-proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80: 1548–1555.

    CAS  PubMed  Google Scholar 

  20. Hills FA, English J, Chard T . Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996; 148: 303–309.

    Article  CAS  Google Scholar 

  21. Qiu Q, Bell M, Lu XY, Yan XJ, Rodger M, Walker M et al. Significance of IGFBP-4 in the development of fetal growth restriction. J Clin Endocrinol Metab 2012; 97: E1429–E1439.

    Article  CAS  Google Scholar 

  22. Ferraro ZM, Qiu Q, Gruslin A, Adamo KB . Characterization of the insulin-like growth factor axis in term pregnancies complicated by maternal obesity. Hum Reprod 2012; 27: 2467–2475.

    Article  CAS  Google Scholar 

  23. Collet C, Candy J . How many insulin-like growth factor binding proteins? Mol Cell Endocrinol 1998; 139: 1–6.

    Article  CAS  Google Scholar 

  24. Evdokimova V, Tognon CE, Benatar T, Yang W, Krutikov K, Pollak M et al. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors. Sci Signal 2012; 5: ra92.

    Article  Google Scholar 

  25. Rajwani A, Ezzat V, Smith J, Yuldasheva NY, Duncan ER, Gage M et al. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes 2012; 61: 915–924.

    Article  CAS  Google Scholar 

  26. Colomiere M, Permezel M, Lappas M . Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol 2010; 44: 213–223.

    Article  CAS  Google Scholar 

  27. Catalano PM, Nizielski SE, Shao JH, Preston L, Qiao LP, Friedman JE . Downregulated IRS-1 and PPAR gamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002; 282: E522–E533.

    Article  CAS  Google Scholar 

  28. Sferruzzi-Perri AN, Owens JA, Standen P, Taylor RL, Heinemann GK, Robinson JS et al. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. Am J Physiol Endocrinol Metab 2007; 292: E668–E676.

    Article  CAS  Google Scholar 

  29. Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG . Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J Reprod Med 1994; 39: 249–256.

    CAS  PubMed  Google Scholar 

  30. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001; 44: 333–339.

    Article  CAS  Google Scholar 

  31. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM . Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 371–376.

    Article  CAS  Google Scholar 

  32. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes 1997; 21: 355–359.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I would like to gratefully acknowledge the assistance of the Clinical Research Midwives Gabrielle Fleming, Astrid Tiefholz, Lyndall Paolucci, Debra Jinks and Asha Ferguson, and the Obstetrics and Midwifery staff of the Mercy Hospital for Women for their co-operation. Associate Professor Martha Lappas is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; Grant No. 1047025). The work described in this manuscript was funded by a project grant from the NHMRC (Grant No. 454310), Diabetes Australia Research Trust (DART) and the Medical Research Foundation for Women and Babies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Lappas.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lappas, M. Insulin-like growth factor-binding protein 1 and 7 concentrations are lower in obese pregnant women, women with gestational diabetes and their fetuses. J Perinatol 35, 32–38 (2015). https://doi.org/10.1038/jp.2014.144

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.144

This article is cited by

Search

Quick links